Passa al contenuto
Merck
Tutte le immagini(2)

Documenti fondamentali

P1004

Sigma-Aldrich

Polymyxin B sulfate salt

Sinonimo/i:

Polymixin, Polymixin B, Polymixin B sulfate

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Formula empirica (notazione di Hill):
C55H96N16O13 · 2H2SO4
Numero CAS:
Peso molecolare:
1385.61
Numero CE:
Numero MDL:
Codice UNSPSC:
51283106
NACRES:
NA.76

Origine biologica

Pseudomonas aeruginosa

Livello qualitativo

Stato

powder

Condizioni di stoccaggio

(Tightly closed. Dry. )

Solubilità

water: 50 mg/mL

Spettro attività antibiotica

Gram-negative bacteria
fungi

Modalità d’azione

cell membrane | interferes

Temperatura di conservazione

2-8°C

Stringa SMILE

O=C(C(NC(C(CCN)NC(CCCCC(C)CC)=O)=O)C(C)O)NC(CCN)C(NC(CCNC(C(NC(C(NC(C(CCN)N1)=O)CCN)=O)C(O)C)=O)C(NC(CCN)C(NC(CC2=CC=CC=C2)C(NC(CC(C)C)C1=O)=O)=O)=O)=O.O=S(O)(O)=O

InChI

1S/C48H82N16O13.H2O4S/c1-27(2)24-37-47(76)59-32(11-19-52)41(70)56-31(10-18-51)43(72)61-35(14-22-65)39(68)54-21-13-34(45(74)57-33(12-20-53)44(73)64-38(48(77)63-37)25-28-6-4-3-5-7-28)60-42(71)30(9-17-50)58-46(75)36(15-23-66)62-40(69)29(8-16-49)55-26-67;1-5(2,3)4/h3-7,26-27,29-38,65-66H,8-25,49-53H2,1-2H3,(H,54,68)(H,55,67)(H,56,70)(H,57,74)(H,58,75)(H,59,76)(H,60,71)(H,61,72)(H,62,69)(H,63,77)(H,64,73);(H2,1,2,3,4)
HNDFYNOVSOOGDU-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

Polymyxin B sulfate is a strongly cationic cyclic polypeptide antibiotic that is derived from fermentation of Bacilus polymyxa. It is a mixture of B1 and B2 sulfate.

Applicazioni

Polymyxin B sulfate is a strongly cationic cyclic polypeptide antibiotic that is derived from fermentation of Bacilus polymyxa. It is a mixture of B1 and B2 sulfate. The product has been used clinically to treat infections of the urinary tract, meninges and blood stream caused by susceptible strains of Pseudomonas aeruginosa. It also has uses studying multidrug-resistant pathogens††, as an immobilized agent for removal of endotoxins, and to induce pore formation in the membranes of cortex cells from excised sorghum roots.
Polymyxin B sulfate salt has been used:
  • in human aortic endothelial cells (HAEC) cell culture to exclude potential endotoxin contamination in recombinant adiponectin
  • in the analysis of the isolates
  • in endotoxin-neutralizing activity of α-amylase (AmyI-1)-18 (LAL assay)

Azioni biochim/fisiol

Mode of Action: Polymyxin B Sulfate binds to the lipid A portion of bacterial lipopolysaccharides†, disrupting the cytoplasmic membrane by inducing pores large enough to permit nucleotide leakage in bacterial walls. This disrupts the permeability of the cytoplasmic membrane.

Antimicrobial spectrum: Has bactericidal action on most gram-negative bacilli††, including E. Coli and on most fungi and gram-positive bacteria.
Polymyxin B is one of the most important antibiotics used to treat gram-negative bacterial infections, including infections caused by carbapenem-resistant non-fermenters and carbapenem-resistant Enterobacteriaceae.

Caratteristiche e vantaggi

High quality antibiotic suitable for mulitple research applications

Nota sulla preparazione

Polymyxin B sulfate is soluble in water at 50 mg/mL, producing a very slightly hazy, colorless to yellow solution. It has only minimal solubility in any organic solvent. For example, it has a solubility of 0.115 mg/mL in ethanol.

Stock solutions should be sterile filtered and stored at 2-8°C. They are stable at 37°C for 5 days.

Stoccaggio e stabilità

As supplied, the product should be stored at 2-8°C in the dark. No change was observed in retained samples after three years′ of storage in these conditions.

Altre note

For additional information on our range of Biochemicals, please complete this form.
Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place.

Pittogrammi

Exclamation mark

Avvertenze

Warning

Indicazioni di pericolo

Classi di pericolo

Acute Tox. 4 Oral

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Dispositivi di protezione individuale

dust mask type N95 (US), Eyeshields, Gloves


Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 4

1 of 4

Colistina ≥19,000 IU/mg

Sigma-Aldrich

C4461

Colistina

Polymyxin B Sulfate Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1595

Polymyxin B Sulfate

Vancomicina ≥900 μg per mg (as vancomycin base)

Sigma-Aldrich

V2002

Vancomicina

Bacitracin from Bacillus licheniformis, ≥65 IU/mg

Sigma-Aldrich

B0125

Bacitracin

Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-kappaB/COX-2 signaling in human aortic endothelial cells
Addabbo F, et al.
American Journal of Physiology. Endocrinology and Metabolism, 301(6), E1143-E1143 (2011)
Biochemical and toxic diversity of Bacillus cereus in a pasta and meat dish associated with a food-poisoning case
Pirhonen T I, et al.
Food Microbiology, 22(1), 87-91 (2005)
Dosing and pharmacokinetics of polymyxin B in patients with renal insufficiency
Thamlikitkul V, et al.
Antimicrobial Agents and Chemotherapy, e01337-e01316 (2017)
Xucheng Huang et al.
International journal of medical microbiology : IJMM, 308(7), 819-828 (2018-07-24)
Ureaplasma spp. are known to be associated with human genitourinary tract diseases and perinatal diseases and Ureaplasma spp. Lipid-associated membrane proteins (LAMPs) play important roles in their related diseases. However, the exact mechanism underlying pathogenesis of Ureaplasma spp. LAMPs is
Alexandre Prehn Zavascki et al.
The Journal of antimicrobial chemotherapy, 60(6), 1206-1215 (2007-09-20)
Polymyxins have re-emerged in clinical practice owing to the dry antibiotic development pipeline and worldwide increasing prevalence of nosocomial infections caused by multidrug-resistant (MDR) Gram-negative bacteria. Polymyxin B and colistin (polymyxin E) have been ultimately considered as the last-resort treatment

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.